InsidersTradesSigma
Track the 바이오에프디엔씨 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바이오에프디엔씨 has logged 3 insider filings. Market capitalisation: €66.5bn. The latest transaction was filed on 8 April 2026 (Other). Among the most active insiders: 모상현. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioFDNC is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the medical field.